Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive
(Reuters Health)

Initial data from clinical trials testing whether patients with severe coronavirus illness can be helped by a rheumatoid arthritis drug sold by Regeneron Pharmaceuticals Inc and Sanofi SA may come as early as next week, Regeneron`s chief scientific officer told Reuters.